Solid Oral Formulation Of Fenretinide - EP3171860

The patent EP3171860 was granted to Laurent Pharmaceuticals on Dec 11, 2024. The application was originally filed on Jul 24, 2015 under application number EP15825528A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3171860

LAURENT PHARMACEUTICALS
Application Number
EP15825528A
Filing Date
Jul 24, 2015
Status
Granted And Under Opposition
Nov 8, 2024
Grant Date
Dec 11, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

WUESTHOFF & WUESTHOFFSep 9, 2025ADMISSIBLE

Patent Citations (30) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2006264514
DESCRIPTIONUS2012093718
DESCRIPTIONUS5516792
DESCRIPTIONUS5574177
DESCRIPTIONUS5599953
DESCRIPTIONUS5663377
DESCRIPTIONUS7780988
DESCRIPTIONUS7887840
DESCRIPTIONWO02058689
DESCRIPTIONWO2005084657
DESCRIPTIONWO2007068116
DESCRIPTIONWO2007136636
DESCRIPTIONWO2009103106
DESCRIPTIONWO2009114136
DESCRIPTIONWO2012078525
DESCRIPTIONWO2014169355
INTERNATIONAL-SEARCH-REPORTUS2006078615
INTERNATIONAL-SEARCH-REPORTUS2010008896
INTERNATIONAL-SEARCH-REPORTUS7780988
INTERNATIONAL-SEARCH-REPORTWO2008006007
INTERNATIONAL-SEARCH-REPORTWO2009106663
OPPOSITIONUS2005106216
OPPOSITIONUS2007099996
OPPOSITIONUS2012093718
OPPOSITIONUS8158152
OPPOSITIONWO2005011636
OPPOSITIONWO2005084657
OPPOSITIONWO2007068116
OPPOSITIONWO2012078525
SEARCHUS2012093718

Non-Patent Literature (NPL) Citations (22) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ANDING et al., Cancer Res., (20070000), vol. 67, pages 6270 - 6277-
DESCRIPTION- "Atomization and Spray-Drying", MARSHALL, Chem. Eng. Prog. Monogr. Series, (19540000), vol. 50, page 2-
DESCRIPTION- BHATNAGAR et al., Biochem. Pharmacol., (19910000), vol. 41, pages 1471 - 7-
DESCRIPTION- CHARLES et al., Cancer Chemother. Pharmacol., (20010000), vol. 47, pages 444 - 450-
DESCRIPTION- CHEMICAL ABSTRACTS, Database accession no. 65646-68-6-
DESCRIPTION- GARAVENTA et al., Clin. Cancer Res., (20030000), vol. 9, pages 2032 - 2039-
DESCRIPTION- KASHAPPA-GOUD et al., Pharmaceutical Research, (20110000), vol. 28, pages 2599 - 2609-
DESCRIPTION- KUMMAR et al., Anticancer Research, (20110000), vol. 31, no. 3, pages 961 - 966-
DESCRIPTION- LIPPMAN et al., J. Natl. Cancer Inst., (20010000), vol. 93, pages 605 - 618-
DESCRIPTION- MARSHALL, "Atomization and Spray-Drying", Chem. Eng. Prog. Monogr. Series, (19540000), vol. 50, page 2-
DESCRIPTION- MAURER BJ, Clin Cancer Res, (20070000), vol. 13, pages 3079 - 3086-
DESCRIPTION- MIRELLA et al., Journal of microencapsulation, (20130000), vol. 31, pages 41 - 48-
DESCRIPTION- PONTHAN et al., Oncol. Rep., (20030000), vol. 10, pages 1587 - 1592-
DESCRIPTION- PUDUVALLI et al., Clin. Cancer Res., (19990000), vol. 5, pages 2230 - 2235-
DESCRIPTION- RAO et al., Breast Cancer Res. Treat., (19980000), vol. 48, pages 265 - 271-
OPPOSITION- Williams et al., Formulating Poorly Water-Soluble Drugs, Springer, (2012), pages 1 - 659, doi:10.1007/978-1-4614-1144-4, ISBN 978-1-4614-1143-7-
OPPOSITION- Kashappa-Goud H. Desai; Susan R. Mallery; Andrew S. Holpuch; Steven P. Schwendeman, "Development and-Evaluation of Fenretinide-Loaded Oral Mucoadhesive Patches for Site-Specific Chemoprevention of Oral Cancer", Pharmaceutical Research, Kluwer Academic Publishers-Plenum Publishers, NL, NL , (20110615), vol. 28, no. 10, doi:10.1007/s11095-011-0489-3, ISSN 1573-904X, pages 2599 - 2609, XP019950364
OPPOSITION- Ledet Grace A.; Graves Richard A.; Glotser Elena Y.; Mandal Tarun K.; Bostanian Levon A., "Preparation andin vitroevaluation of hydrophilic fenretinide nanoparticles", International Journal of Pharmaceutics, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL, (20141224), vol. 479, no. 2, doi:10.1016/j.ijpharm.2014.12.052, ISSN 0378-5173, pages 329 - 337, XP029143911
OPPOSITION- Guilbault Claudine, De Sanctis Juan B., Wojewodka Gabriella, Saeed Zienab, Lachance Claude, Skinner Thomas A. A., Vilela Regina M., Kubow Stan, Lands Larry C., Hajduch Marian, Matouk Elias, Radzioch Danuta, "Fenretinide Corrects Newly Found Ceramide Deficiency in Cystic Fibrosis", AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY., AMERICAN LUNG ASSOCIATION, NEW YORK, NY, US, NEW YORK, NY, US , (20080101), vol. 38, no. 1, doi:10.1165/rcmb.2007-0036OC, ISSN 1044-1549, pages 47 - 56, XP093315512
OPPOSITION- Po-Chang Chiang; Yingqing Ran; Kang-Jye Chou; Yong Cui; Amy Sambrone; Connie Chan; Ryan Hart, "Evaluation of Drug Load and Polymer by Using a 96-Well Plate Vacuum Dry System for Amorphous Solid Dispersion Drug Delivery", AAPS PHARMSCITECH, Springer New York LLC, US, US , (20120505), vol. 13, no. 2, doi:10.1208/s12249-012-9795-2, ISSN 1530-9932, pages 713 - 722, XP035064306
SEARCH- KASHAPPA-GOUD H DESAI ET AL, "Development and-Evaluation of Fenretinide-Loaded Oral Mucoadhesive Patches for Site-Specific Chemoprevention of Oral Cancer", PHARMACEUTICAL RESEARCH, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NL, (20110615), vol. 28, no. 10, doi:10.1007/S11095-011-0489-3, ISSN 1573-904X, pages 2599 - 2609, XP019950364 [X] 1,5,11,16 * page 2600, paragraphs 3, 4; figure 1 * * Preparation of Oral Mucoadhesive Patches for Delivery of Fenretinide; page 2601, paragraphs 4, 5 * * page 2604; table 1 * * page 2605; figure 3 * * Conclusions; page 2607 *
SEARCH- MIRELLA FALCONI ET AL, "Novel PLA microspheres with hydrophilic and bioadhesive surfaces for the controlled delivery of fenretinide", JOURNAL OF MICROENCAPSULATION., GB, (20130718), vol. 31, no. 1, doi:10.3109/02652048.2013.805838, ISSN 0265-2048, pages 41 - 48, XP055386208 [X] 1,5,11,16 * Preparation of PLA and PLGA microspheres; page 2; figure 1 * * page 3; table 1 * * page 4; table 2 * * Conclusions; page 7 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents